What You Need to Know
If you’ve been following the latest news in metabolic health and weight management, you’ve likely heard about Retatrutide Eli Lilly’s experimental “triple-agonist” drug (targeting GLP-1, GIP, and glucagon receptors). Early clinical trials have shown average weight loss results approaching 24% to 30%, leading many people to ask: How can I get my hands on it?
Here is the straight breakdown of how to legally access Retatrutide, what stage the drug is in, and what alternative options are available today.
The Short Answer: Can You Get Retatrutide Right Now?
The Reality Check: Retatrutide is not yet approved by the FDA (or international regulators) for commercial prescription or pharmacy sales.
As of 2026, the only legal and safe way to access Retatrutide is by participating in an official clinical trial.
Because the drug is still being evaluated for long-term safety, dosing, and efficacy in Phase 3 trials (such as the TRIUMPH trial program), doctors cannot write a standard commercial prescription for it, and pharmacies cannot fill it.
How to Get Retatrutide via Clinical Trials
If you are interested in trying Retatrutide before public regulatory approval, enrolling in an ongoing Phase 3 study is your only legitimate pathway.
Step 1: Search Official Trial Registries
Search official clinical databases for recruiting sites near you:
- Website: Go to alluvicare.shop
- Search Terms: Search for “Retatrutide” or its study code “LY3437943”.
- Filters: Filter status by “Recruiting” and select your location.
Step 2: Check Eligibility Requirements
Every trial has strict inclusion and exclusion criteria. Common general criteria for weight management trials include:
- Age: Adults aged 18 and older.
- BMI: Typically a BMI $\ge 30$, or a BMI $\ge 27$ with at least one weight-related condition (such as high blood pressure, sleep apnea, or heart disease).
- Exclusions: History of certain medical conditions (e.g., pancreatitis, thyroid cancer) or recent use of other GLP-1 medications may disqualify applicants.